...的临床意义，于是通过统计、研究、分析行冠脉造影检查的临床患者，估计的肾小球滤过率（estimated glomerular filtration rate，eGFR）与冠心病传统危险因素的相关性。
基于12个网页-相关网页
估算的肾小球滤过率(esti mated glomerular filtration rate,eGFR)是反映肾脏整体功能的最重要指标,为公认的重要的监测肾功能的指标[7-8]。
基于4个网页-相关网页
...患者可很好耐受ACEI/ARB类药物，但此两类药物可降低肾小球毛细血管静水压，引起短暂的肾小球滤过率(Glomerular filtration rate,GFR)降低、血肌酐升高。
基于1个网页-相关网页
估计的肾小球滤过率 estimate glomerular filtration rate ; EGFR
以估算的肾小球滤过率 estimated glomerular filtration rate
评估的肾小球滤过率 estimated glomerular filtration
估算的肾小球滤过率 estimated glomerular filtration rate
和估算的肾小球滤过率 estimated glomerular filtration rate
肾小球的滤过率 glomerular filtration rate ; GFR
肾单位的小球滤过率 single nephron GFR
初级评估疗效指标是肾小球过滤率的变化，观察在18个月和36个月（3年）的肾小球滤过率（GFR）变化。
The primary outcome measure was progression of nephropathy, which was assessed by change in glomerular filtration rate (GFR) at 18 and 36 months.
低的肾小球滤过率是存在糖尿病肾损害的危险信号，糖尿病肾损害最终会进展为肾衰，即终末期肾损害，此时需要透析治疗或肾脏移植。
A low GFR is a dangerous sign of existing diabetic kidney disease that can progress to kidney failure, also called end-stage kidney disease, which requires dialysis or kidney transplantation.
次要结果包括24小时血压和肾小球滤过率（GFR）的改变。
Secondary measures included change in 24-h blood pressure and glomerular filtration rate (GFR).
应用推荐